|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar
|
|
2
|
Lee HP: Annual report of gynecologic
cancer registry program in Korea: 1991–2004. Korean J Obstet
Gynecol. 51:1411–1420. 2008.
|
|
3
|
Lax SF: Molecular genetic pathways in
various types of endometrial carcinoma: from a phenotypical to a
molecular-based classification. Virchows Arch. 444:213–223. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zannoni GF, Scambia G and Gallo D: The
dualistic model of endometrial cancer: the challenge of classifying
grade 3 endometrioid carcinoma. Gynecol Oncol. 127:262–263. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rose PG: Endometrial carcinoma. N Engl J
Med. 335:640–649. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schafer BW and Heizmann CW: The S100
family of EF-hand calcium-binding proteins: functions and
pathology. Trends Biochem Sci. 21:134–140. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mazzucchelli L: Protein S100A4: too long
overlooked by pathologists? Am J Pathol. 160:7–13. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schmidt-Hansen B, Klingelhöfer J,
Grum-Schwensen B, Christensen A, Andresen S, Kruse C, Hansen T,
Ambartsumian N, Lukanidin E and Grigorian M: Functional
significance of metastasis-inducing S100A4(Mts1) in tumor-stroma
interplay. J Biol Chem. 279:24498–24504. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ismail NI, Kaur G, Hashim H and Hassan MS:
S100A4 overexpression proves to be independent marker for breast
cancer progression. Cancer Cell Int. 8:122008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Trujillo KA, Heaphy CM, Mai M, Vargas KM,
Jones AC, Vo P, Butler KS, Joste NE, Bisoffi M and Griffith JK:
Markers of fibrosis and epithelial to mesenchymal transition
demonstrate field cancerization in histologically normal tissue
adjacent to breast tumors. Int J Cancer. 129:1310–1321. 2011.
View Article : Google Scholar
|
|
11
|
Platt-Higgins AM, Renshaw CA, West CR,
Winstanley JH, De Silva Rudland S, Barraclough R and Rudland PS:
Comparison of the metastasis-inducing protein S100A4 (p9ka) with
other prognostic markers in human breast cancer. Int J Cancer.
89:198–208. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pedersen KB, Nesland JM, Fodstad Ø and
Maelandsmo GM: Expression of S100A4, E-cadherin, α- and β-catenin
in breast cancer biopsies. Br J Cancer. 87:1281–1286. 2002.
|
|
13
|
Wang YY, Ye ZY, Zhao ZS, Tao HQ and Chu
YQ: High-level expression of S100A4 correlates with lymph node
metastasis and poor prognosis in patients with gastric cancer. Ann
Surg Oncol. 17:89–97. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huang LY, Xu Y, Cai GX, Guan ZQ, Sheng WQ,
Lu HF, Xie LQ, Lu HJ and Cai SJ: S100A4 over-expression underlies
lymph node metastasis and poor prognosis in colorectal cancer.
World J Gastroenterol. 17:69–78. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kang YG, Jung CK, Lee A, Kang WK, Oh ST
and Kang CS: Prognostic significance of S100A4 mRNA and protein
expression in colorectal cancer. J Surg Oncol. 105:119–124. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kwak JM, Lee HJ, Kim SH, Kim HK, Mok YJ,
Park YT, Choi JS and Moon HY: Expression of protein S100A4 is a
predictor of recurrence in colorectal cancer. World J
Gastroenterol. 16:3897–3904. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen D, Zheng XF, Yang ZY, Liu DX, Zhang
GY, Jiao XL and Zhao H: S100A4 silencing blocks invasive ability of
esophageal squamous cell carcinoma cells. World J Gastroenterol.
18:915–922. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nakamura T, Ajiki T, Murao S, Kamigaki T,
Maeda S, Ku Y and Kuroda Y: Prognostic significance of S100A4
expression in gallbladder cancer. Int J Oncol. 20:937–941.
2002.PubMed/NCBI
|
|
19
|
Kikuchi N, Horiuchi A, Osada R, Imai T,
Wang C, Chen X and Konishi I: Nuclear expression of S100A4 is
associated with aggressive behavior of epithelial ovarian
carcinoma: an important autocrine/paracrine factor in tumor
progression. Cancer Sci. 97:1061–1069. 2006. View Article : Google Scholar
|
|
20
|
Davies BR, O’Donnell M, Durkan GC, Rudland
PS, Barraclough R, Neal DE and Mellon JK: Expression of S100A4
protein is associated with metastasis and reduced survival in human
bladder cancer. J Pathol. 196:292–299. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Min HS, Choe G, Kim SW, Park YJ, Park do
J, Youn YK, Park SH, Cho BY and Park SY: S100A4 expression is
associated with lymph node metastasis in papillary microcarcinoma
of the thyroid. Mod Pathol. 21:748–755. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zou M, Al-Baradie RS, Al-Hindi H, Farid NR
and Shi Y: S100A4 (Mts1) gene overexpression is associated with
invasion and metastasis of papillary thyroid carcinoma. Br J
Cancer. 93:1277–1284. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tsuna M, Kageyama S, Fukuoka J, Kitano H,
Doki Y, Tezuka H and Yasuda H: Significance of S100A4 as a
prognostic marker of lung squamous cell carcinoma. Anticancer Res.
29:2547–2554. 2009.PubMed/NCBI
|
|
24
|
Xie R, Loose DS, Shipley GL, Xie S,
Bassett RL Jr and Broaddus RR: Hypomethylation-induced expression
of S100A4 in endometrial carcinoma. Mod Pathol.
20:1045–1054. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cho YG, Kim CJ, Nam SW, Yoon SH, Lee SH,
Yoo NJ, Lee JY and Park WS: Overexpression of S100A4 is closely
associated with progression of colorectal cancer. World J
Gastroenterol. 11:4852–4856. 2005.PubMed/NCBI
|
|
26
|
Bolander A, Agnarsdóttir M, Wagenius G,
Strömberg S, Pontén F, Ekman S, Brattström D, Larsson A, Einarsson
R, Ullenhag G, Hesselius P and Bergqvist M: Serological and
immunohistochemical analysis of S100 and new derivatives as markers
for prognosis in patients with malignant melanoma. Melanoma Res.
18:412–419. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jung EA, Cho HD, Lee JH and Oh MH:
Clinicopathological significance of S100A4 expression in non-small
cell lung carcinomas. Korean J Pathol. 44:477–482. 2010. View Article : Google Scholar
|
|
28
|
Li Y, Liu ZL, Zhang KL, Chen XY, Kong QY,
Wu ML, Sun Y, Liu J and Li H: Methylation-associated silencing of
S100A4 expression in human epidermal cancers. Exp Dermatol.
18:842–848. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rehman I, Goodarzi A, Cross SS, Leiblich
A, Catto JW, Phillips JT and Hamdy FC: DNA methylation and
immunohistochemical analysis of the S100A4 calcium binding protein
in human prostate cancer. Prostate. 67:341–347. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Grigorian M, Andresen S, Tulchinsky E,
Kriajevska M, Carlberg C, Kruse C, Cohn M, Ambartsumian N,
Christensen A, Selivanova G and Lukanidin E: Tumor suppressor p53
protein is a new target for the metastasis-associated Mts1/S100A4
protein: functional consequences of their interaction. J Biol Chem.
276:22699–22708. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Flatmark K, Pedersen KB, Nesland JM,
Rasmussen H, Aamodt G, Mikalsen SO, Bjørnland K, Fodstad Ø and
Maelandsmo GM: Nuclear localization of the metastasis-related
protein S100A4 correlates with tumour stage in colorectal cancer. J
Pathol. 200:589–595. 2003. View Article : Google Scholar : PubMed/NCBI
|
